On Wednesday, Abbott Laboratories posted revenue declines that were foreign currency driven in its most recent quarter. However, the company raised its guidance for the year adding that it saw gains on a constant currency basis across every segment. Overall revenue was down 0.2% while its operational revenue, which excludes currency changes, was up 5.1%. […]